期刊文献+

缬沙坦合卡维地洛治疗慢性心力衰竭43例临床疗效观察 被引量:3

下载PDF
导出
摘要 目的:探讨缬沙坦合卡维地洛治疗慢性心力衰竭患者的临床疗效。方法:选取86例慢性心力衰竭患者作为研究对象,将其按照入院时间顺序分成对照组和治疗组,对照组患者接受单纯卡维地洛进行治疗;治疗组患者接受缬沙坦与卡维地洛联合治疗。结果:治疗组患者治疗总有效率为90.7%,明显优于对照组的72.1%,差异具有统计学意义(P<0.05);治疗前后LVEDD和LVESD水平的改善幅度明显大于对照组,差异具有统计学意义(P<0.05)。结论:缬沙坦合卡维地洛治疗慢性心力衰竭临床疗效较好。
作者 陈正汗
出处 《中国民族民间医药》 2014年第5期48-48,共1页 Chinese Journal of Ethnomedicine and Ethnopharmacy
  • 相关文献

参考文献4

二级参考文献34

  • 1王允,刘王明,张虹,韩震.卡维地洛与美托洛尔治疗慢性心力衰竭的疗效比较[J].苏州大学学报(医学版),2004,24(6):902-903. 被引量:3
  • 2柏山.卡维地洛在慢性心力衰竭中的对照研究[J].现代医药卫生,2006,22(21):3240-3241. 被引量:2
  • 3[1]Macdonald PS,Hill J,Krum H.COLA Ⅱ Investigators.The impact of baseline HR and BP on the tolerability of carvedilol in the elderly:the COLA (Carvedilol Open Label Assessment) Ⅱ Study[J].Am J Cardiovasc Drugs,2006,6(6):401-405.
  • 4[2]Dobre D,van Veldhuisen DJ.SENIORS Investigators.Tolerability and dose-related effects of nebivolol in elderly patients with heart failure:data from the Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure (SENIORS) trial[J].Am Heart J,2007,154 (1):109-115.
  • 5[3]Willenheimer R,van Veldhuisen DJ,CIBIS Ⅲ Investigators.Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril,as compared with the opposite sequence:results of the randomized Cardiac Insufficiency Bisoprolol Study (CIBIS) Ⅲ.Circulation,2005,112(16):2426-2435.
  • 6[4]Chuen M J,MacFadyen RJ.Dose-dependent association between use of loop diuretics and mortality in advanced systolic heart failure[J].Am J Cardiol,2006,98(10):1416-1417.
  • 7[5]Gheorghiade M,Konstam MA,Burnett JC Jr,et al.Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) Investigators.Shortterm clinical effects of tolvaptan,an oral vasopressin antagonist,in patients hospitalized for heart failure:the EVEREST Clinical Status Trials[J].JAMA,2007,297 (12):1332-1343.
  • 8[6]Konstam MA,Gheorghiade M,Burnett JC Jr,et al.Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) Investigators.Effects of oral tolvaptan in patients hospitalized for worsening heart failure:the EVEREST Outcome Trial[J].JAMA,2007,297(12):1319-1331.
  • 9[7]Cleland JG,Coletta AP,Clark AL.Clinical trials update from the American College of Cardiology 2007:ALPHA,EVEREST,FUSION Ⅱ,VALIDD,PARR-2,REMODEL,SPICE,COURAGE,COACH,REMADHE,pro-BNP for the evaluation of dyspnoea and THIS-diet[J].Eur J Heart Fail,2007,9(6-7):740-745.
  • 10[8]Go AS,Lee WY,Yang J,et al.Statin therapy and risks for death and hospitalization in chronic heart failure[J].JAMA.2006,296(17):2105-2111.

共引文献69

同被引文献19

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部